FertilitransFertility Preservation Decisions and Regret in Italian Transgender Adults
Data Collection
Collected at a single point in time - Cross-sectionalOther
Utilizing specific methods not covered by standard models in order to address unique research questions.Summary
Study start date: March 29, 2025
Actual date on which the first participant was enrolled.This study focuses on understanding the decisions transgender individuals in Italy make regarding fertility preservation before undergoing gender-affirming treatments that can affect reproductive capabilities. These treatments, such as hormone therapy or surgeries, might impact the ability to have biological children in the future. The study aims to discover why some choose to preserve fertility through methods like freezing eggs or sperm, while others do not, and to explore their feelings about these decisions afterward. This research is important as it seeks to improve the advice and support provided to transgender individuals, helping them make informed choices that align with their personal goals and improve their quality of life. Participants in the study will be transgender adults who will complete a detailed survey about their experiences and decisions regarding fertility preservation. This survey will ask about their transition history, reasons for preserving or not preserving fertility, the type of counseling they received, and any regrets they might have. It will also assess the challenges they faced, such as financial or emotional barriers. The study will use a specific scale to measure decision regret, aiming to identify what factors contribute to feelings of regret. By analyzing this information, the study hopes to identify ways to offer better support and counseling tailored to the needs of the transgender community.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.616 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, ItalyOpen IRCCS Azienda Ospedaliero-Universitaria di Bologna in Google Maps